The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis
β Scribed by Maetzel, Andreas ;Krahn, Murray ;Naglie, Gary
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 122 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions